Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
557
datasets available to search
ShareScore release 0.9.0
Dataset results
557 results for “imatinib”
Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients
ClinicalTrials.gov study NCT01511289. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00030394. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma
ClinicalTrials.gov study NCT00031915. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST Patients
ClinicalTrials.gov study NCT01735968. IPD Sharing: NO. Countries: 8. Publications: 1.
Imatinib Mesylate in Treating Patients With Gliomas
ClinicalTrials.gov study NCT00039364. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Discontinuation Study of Imatinib in Adult CP CML Patients Who Have a Complete Molecular Response to Imatinib
ClinicalTrials.gov study NCT01564836. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery
ClinicalTrials.gov study NCT00025246. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)
ClinicalTrials.gov study NCT03722420. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Imatinib Mesylate in Treating Patients With Salivary Gland Cancer
ClinicalTrials.gov study NCT00045669. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma
ClinicalTrials.gov study NCT00193258. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML.
ClinicalTrials.gov study NCT01130688. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00478985. IPD Sharing: Not stated. Countries: 1. Publications: 3.
POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST
ClinicalTrials.gov study NCT03171389. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Intermittent Imatinib Treatment in Chronic Myeloid Leukemia and Philadelphia Chromosome (Ph+CML) Patients Who Achieved a Complete Cytogenetic Response (CCgR) on Standard Imatinib Therapy
ClinicalTrials.gov study NCT00858806. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of AMN107 in Patients With GastroIntestinal Stromal Tumors (GIST) Who Have Failed Both Imatinib and Sunitinib
ClinicalTrials.gov study NCT00718562. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response
ClinicalTrials.gov study NCT02852486. IPD Sharing: YES. Countries: 1. Publications: 15.
Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes
ClinicalTrials.gov study NCT00787384. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor
ClinicalTrials.gov study NCT00103168. IPD Sharing: Not stated. Countries: 6. Publications: 2.
Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma
ClinicalTrials.gov study NCT00401024. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I)
ClinicalTrials.gov study NCT01751919. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.